Chloroquine Enhances the Number of IL‐10 Producing Cells and the Expression of B7‐2 and ICAM‐1 in In Vitro‐Cultured PBMC

Scandinavian Journal of Immunology - Tập 55 Số 4 - Trang 399-408 - 2002
Elisabeth Hugosson1,2, Anders Björkman2, Marita Troye‐Blomberg1
1The Department of Immunology, Stockholm University
2The Department of Infectious Diseases, Karolinska Hospital, Karolinska Institutet, Stockholm, Sweden

Tóm tắt

Chloroquine is prescribed as both an anti‐malarial and an anti‐inflammatory drug. However, its immuno‐modulating effects remain largely unclear. Previous studies have shown that chloroquine inhibits antigen‐induced proliferation, implying immuno‐suppressive effects. In this study, we examined whether the inhibition of the proliferation reflects changes in the surface molecules that are important for T‐cell activation and whether chloroquine affects the balance between pro‐ and anti‐inflammatory cytokines. Chloroquine elevated the expression of the costimulatory and adhesion molecules B7‐2 (CD86) and ICAM‐1 (CD54) in peripheral mononuclear cells (PBMC). An increased percentage of CD14+ cells was also observed, and within this cell population, an increase in ICAM‐1 expression was revealed by double‐staining experiments. Assessment of the frequencies of interleukin (IL)‐10 and interferon (IFN)‐γ‐producing cells in in vitro‐cultivated PBMCs showed that the ratio between pro‐ and anti‐inflammatory cytokines changed after exposure to chloroquine, favouring anti‐inflammatory immune responses. This effect was mainly because of increased frequencies of IL‐10‐producing cells and was seen with or without the presence of stimulating antigens or mitogens. Our findings indicate that chloroquine affects the direction of the lymphocyte stimulation towards an anti‐inflammatory response by affecting the antigen‐presenting cells (APC) and the balance between pro‐ and anti‐inflammatory cytokines, rather than generally inhibiting cytokine production.

Từ khóa


Tài liệu tham khảo

10.1136/ard.57.10.582

10.1016/S0035-9203(98)90962-2

10.1016/S0952-7915(05)80018-4

10.1128/IAI.64.2.535-541.1996

Waki S, 1992, The role of T cells in pathogenesis and protective immunity to murine malaria, Immunology, 75, 646

10.1111/j.1365-2141.1988.tb02440.x

Taverne J, 1994, Aneamia and resistance to malaria in transgenic mice expressing human tumour necrosis factor, Immunology, 82, 397

10.1126/science.3306918

10.1056/NEJM198906153202404

10.1016/0140-6736(90)92827-5

Picot S, 1993, Chloroquine‐induced inhibition of the production of TNF, but not of IL‐6, is affected by disruption of iron metabolism, Immunology, 80, 127

Ertel W, 1991, Chloroquine attenuates hemorrhagic shock‐induced suppression of kupffer cell antigen presentation and major histocompatibility complex class II antigen expression through blockade of tumor necrosis factor and prostaglandin release, Blood, 78, 1781, 10.1182/blood.V78.7.1781.1781

Landewe R, 1992, Cyclosporine and chloroquine synergistically inhibit the IFN‐gamma production by CD4‐positive and CD8‐positive T cell clones derived from a patient with rhematoid arthritis, J Rheumatol, 19, 1353

Van Den Borne B, 1997, Chloroquine and hydroxychloroquine equally affect tumor necrosis factor‐α, interleukin 6, and interferon‐γ production by peripheral blood mononuclear cells, J Rheumatol, 24, 55

10.1152/ajpregu.1998.274.4.R1058

Jeong J, 1997, Chloroquine inhibits processing of tumor necrosis factor in lipopolysaccharide‐stimulated RAW 264.7 macrophages, J Immunol, 158, 4901, 10.4049/jimmunol.158.10.4901

Chesnut R, 1982, Requirements for the processing of antigens by antigen‐presenting B cells. I. Functional comparison of B cell tumors and macrophages, J Immunol, 129, 2382, 10.4049/jimmunol.129.6.2382

10.1073/pnas.89.6.2252

10.1111/j.1365-2249.1995.tb06648.x

10.1016/0309-1651(90)90069-B

10.1038/383787a0

Stevenson M, 1995, IL‐12‐induced protection against blood‐stage Plasmodium chaubaudi AS requires IFN‐γ and TNF‐α and occurs via a nitric oxide‐dependent mechanism, J Immunol, 155, 2545, 10.4049/jimmunol.155.5.2545

10.1016/0092-8674(93)80068-P

10.1016/S0167-5699(05)80015-5

10.1084/jem.174.4.915

10.4049/jimmunol.151.3.1224

10.1182/blood.V89.12.4461

10.1016/0092-8674(95)90349-6

10.1111/j.1365-3083.1980.tb00072.x

10.1002/eji.1830200521

10.1097/00007890-199004000-00023

10.1046/j.1365-2222.1997.560878.x

10.1086/314548

10.1016/S0140-6736(97)09439-7

10.1016/S0065-2776(08)60620-3

Hellgren U, 1989, Response of Plasmodium falciparum to chloroquine treatment: relation to whole blood concentrations of chloroquine and desethylchloroquine, Bull World Health Organ, 67, 197

10.1016/0035-9203(86)90021-0

10.1093/intimm/11.12.2015

10.1073/pnas.87.14.5484

10.1002/eji.1830240435

Vespa L, 1989, Expression of I‐a by macrophages from Bcgr and Bcgs mice. Transient expression of I‐a is due to degradation of MHC class II Glycoprotein, J Immunol, 142, 214, 10.4049/jimmunol.143.1.214

10.1084/jem.176.1.287

10.1016/S1074-7613(00)80014-X

Osorio L, 1992, Inhibition of human monocyte function by prophylactic doses of chloroquine, Am J Trop Med Hyg, 46, 165, 10.4269/ajtmh.1992.46.165

Munder M, 1998, Alternative metabolic states in murine macrophages reflected by the nitric oxide synthesase/arginase balanse: competitive regulation by CD4+ T cells correlates with Th1/Th2 phenotype, J Immunol, 160, 5347, 10.4049/jimmunol.160.11.5347

10.1016/0008-8749(90)90211-9

10.2307/3285835

10.1046/j.1365-2567.1999.00718.x